{"id":"https://openalex.org/W2460657334","doi":null,"title":"Treatment of psoriasis with retinoids: present status.","display_name":"Treatment of psoriasis with retinoids: present status.","publication_year":1999,"publication_date":"1999-11-01","ids":{"openalex":"https://openalex.org/W2460657334","mag":"2460657334","pmid":"https://pubmed.ncbi.nlm.nih.gov/10582161"},"language":"en","primary_location":{"id":"pmid:10582161","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10582161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113532492","display_name":"Constantin E. Orfanos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"C E Orfanos","raw_affiliation_strings":["Department of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin, Germany","institution_ids":["https://openalex.org/I75951250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113532492"],"corresponding_institution_ids":["https://openalex.org/I75951250"],"apc_list":null,"apc_paid":null,"fwci":0.2182,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.5072772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"64","issue":"5","first_page":"347","last_page":"53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.8379999995231628},{"id":"https://openalex.org/keywords/acitretin","display_name":"acitretin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/etretinate","display_name":"etretinate","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tazarotene","display_name":"tazarotene","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pustular-psoriasis","display_name":"pustular psoriasis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/erythrodermic-psoriasis","display_name":"erythrodermic psoriasis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.8569999933242798},{"id":"https://openalex.org/keywords/anthralin","display_name":"anthralin","score":0.949999988079071},{"id":"https://openalex.org/keywords/phototherapy","display_name":"phototherapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/teratogenicity","display_name":"teratogenicity","score":0.9639999866485596},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2776705134","wikidata":"https://www.wikidata.org/wiki/Q554297","display_name":"Etretinate","level":3,"score":0.9584547281265259},{"id":"https://openalex.org/C2778496887","wikidata":"https://www.wikidata.org/wiki/Q341500","display_name":"Acitretin","level":3,"score":0.9469975233078003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9414774179458618},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.9320361018180847},{"id":"https://openalex.org/C2779306117","wikidata":"https://www.wikidata.org/wiki/Q3981685","display_name":"Tazarotene","level":3,"score":0.7564332485198975},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7489186525344849},{"id":"https://openalex.org/C2780969348","wikidata":"https://www.wikidata.org/wiki/Q418270","display_name":"Efalizumab","level":4,"score":0.5193139910697937},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.444486141204834},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4372250437736511},{"id":"https://openalex.org/C3020604521","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Plaque psoriasis","level":3,"score":0.43090304732322693},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3222924470901489},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.13228121399879456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11765822768211365},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005050","descriptor_name":"Etretinate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005050","descriptor_name":"Etretinate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007641","descriptor_name":"Keratolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007641","descriptor_name":"Keratolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017255","descriptor_name":"Acitretin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017255","descriptor_name":"Acitretin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10582161","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10582161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Journal Article"},{"id":"mag:2460657334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10582161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2018613851","https://openalex.org/W205507086","https://openalex.org/W2364049899","https://openalex.org/W1972949229","https://openalex.org/W2080089999","https://openalex.org/W2061864733","https://openalex.org/W2140865108","https://openalex.org/W159232951","https://openalex.org/W1848444909","https://openalex.org/W1978122993"],"abstract_inverted_index":{"Oral":[0,45],"retinoids":[1,68],"such":[2],"as":[3],"etretinate/acitretin":[4],"are":[5,16,47,53],"well":[6],"established":[7],"for":[8,19],"the":[9,20,64,88],"treatment":[10],"of":[11,22,66,90],"severe":[12],"generalized":[13],"psoriasis.":[14],"They":[15],"particularly":[17],"useful":[18],"management":[21],"pustular":[23],"and":[24,27,43,55,69,85],"erythrodermic":[25],"variants":[26],"plaque-type":[28],"psoriasis":[29,91],"because":[30],"they":[31],"act":[32],"synergistically":[33],"with":[34],"many":[35],"other":[36],"topical":[37,79],"antipsoriatic":[38],"agents":[39],"(corticosteroids,":[40],"anthralin,":[41],"tar,":[42],"phototherapies).":[44],"regimens":[46],"dose-dependent,":[48],"and,":[49],"if":[50],"carefully":[51],"administered,":[52],"manageable":[54],"tolerable.":[56],"Long-term":[57],"toxicity":[58],"is":[59],"rare;":[60],"however,":[61],"teratogenicity":[62],"restricts":[63],"use":[65],"oral":[67],"requires":[70],"close":[71],"monitoring":[72],"in":[73],"females.":[74],"In":[75],"recent":[76],"years,":[77],"a":[78],"agent,":[80],"tazarotene,":[81],"has":[82],"been":[83],"developed":[84],"added":[86],"to":[87],"armamentarium":[89],"therapy.":[92]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-07-22T00:00:00"}